


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.83%
-13.03%
+10.93%
+2.36%
-17.75%
JNJ
Johnson & Johnson
$207.56
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive

Pays a reliable dividend
Chart
$188.87 (+9.90%)
$178.76 (+16.11%)
$156.28 (+32.81%)
$146.64 (+41.54%)
JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

JNJ overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
JNJ Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
JNJ Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayNBTX
20.38
-4.00%
SNDX
19.87
+2.16%
REGN
784.61
-0.34%
PFE
25.71
-0.02%
PCRX
23.81
+2.76%
What is JNJ current stock price?
What are JNJ stock strengths?
What is JNJ Risk Level?
What is JNJ market cap and volume?
What is JNJ current Stock IQ?
Should I buy JNJ stock right now?
Is JNJ a Strong Buy right now?
What does a 'Strong Buy' rating mean for JNJ?
What does a 'Strong Sell' rating mean for JNJ?
What factors influence JNJ's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.83%
-13.03%
+10.93%
+2.36%
-17.75%
JNJ
Johnson & Johnson
Current Price
$207.56
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive

Pays a reliable dividend
Linked to JNJ
NBTX
20.38
-4.00%
SNDX
19.87
+2.16%
REGN
784.61
-0.34%
PFE
25.71
-0.02%
PCRX
23.81
+2.76%

Chart
$188.87 (+9.90%)
$178.76 (+16.11%)
$156.28 (+32.81%)
$146.64 (+41.54%)
JNJ Analysts Opinion
JNJ Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
JNJ Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
JNJ Street Sentiment is bullish and have positive views on the near-term outlook
JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels.
JNJ Latest Analysis
Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Today
Whats Going On With Johnson & Johnson Stock On Wednesday?. ) stock has surged almost 42.9% in the year to date approximately 35% in 6 months and 8.6% in one month..The rally streak reflects strong third-quarter earnings deals like the .During its most recent quarterly earnings Johnson &. Johnson announced plans to separate its Orthopedics business to enhance strategic and operational focus.The transaction would establish a standalone orthopedics business operating as DePuy Synthes. Johnson &a
Today
J&J Up Around 17% in 3 Months: Should You Buy Sell or Hold the Stock?. J&Js 16.7% rise reflects stronger sales guidance rapid pipeline advances and improving MedTech momentum amid a recovering sector.
Tue Nov 25, 2025
Johnson & Johnson Reaches Analyst Target Price. In recent trading shares of Johnson &. Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $203.50 changing hands for $203.90/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade
Mon Nov 24, 2025
J&J Snack Foods declares $0.80 dividend.
Fri Nov 21, 2025
Noteworthy Thursday Option Activity: JNJ MRNA ALB. Looking at options trading activity among components of the S&.P 500 index there is noteworthy activity today in Johnson &. Johnson (Symbol: JNJ) where a total volume of 39084 contracts has been traded thus far today a contract volume which is representative of approxi
Thu Nov 20, 2025
A Closer Look at Johnson & Johnsons Options Market Dynamics. Investors with a lot of money to spend have taken a ish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with JNJ it often means somebody knows something is about to happen.So how do we know what these investors j
Wed Nov 19, 2025
Why Johnson & Johnsons Share Price Is Popping This Month. Key PointsJ&J beat Wall Street estimates on sales and profits in the third quarter.
Wed Nov 19, 2025
Johnson & Johnson falls after six-sessions of gain.
Tue Nov 18, 2025
J&J Joins Pharma M&A Bandwagon to Buy Cancer Biotech for $3.05B. J&Js $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.
Tue Nov 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.